Scientists discuss what we now know about building your microbiome, food allergies and probiotics

International Women’s Day takes place on March 8, which celebrates the achievements of women, and also shines a light on gender discrimination and the need to accelerate gender parity. 

ClostraBio, a biotech company focused on developing novel therapeutic solutions for diseases of the gut, is excited to announce a major breakthrough in targeted metabolite delivery to transform intestinal health.

UChicago scholar recognized for breakthrough research on microbiome and allergies

New therapeutics are testing whether protective bacteria can dampen harmful immune responses to food.

Trillions of microbes call our body home. Now we’re learning they’re crucial for our health.

How manipulating the microbiome could reverse and prevent peanut allergies and more

As evidence grows that gut bacteria play roles in the development and persistence of food allergies, researchers begin to explore microbe-based interventions.

With the help of the Polsky Center, ClostraBio, a company addressing food allergies, was born.

The proliferation of research pertaining to the human gut microbiome has produced numerous findings that point to its role in a range of illnesses, including gastrointestinal, metabolic, and psychiatric diseases. In addition, emerging evidence suggests that the gut microbiome may contribute to the pathogenesis of atopy and asthma.

Food allergies are on the rise. In the U.S., more than 32 million Americans live with the condition. And while food allergies have been well documented in children, a recent study found that 10 percent of adults have a food allergy, and one in four of them developed that allergy as an adult.

With big pharma and med-tech companies investing less in nascent technologies, schools hoping to commercialize research help profs launch businesses.

Healthy infants have intestinal bacteria that prevent the development of food allergies, new research shows.

This could be a game-changer.

Millions of Americans suffer from food allergies

Study: Intestinal microbes protect against allergic reaction to cow’s milk

The number of people with food allergies has exploded in recent years. A dream team of Chicago researchers and scientists may have figured out why, and now they’re developing therapies that could lead to …

The founders, leaders, technologists, investors, connectors and mentors you need to know in Chicago tech are all here. There’s one difference this year: They’re all women. Yes, women are underrepresented in tech, in Chicago and beyond. But there are plenty of awesome women to be found. You just have to look. 

Prof. Cathryn Nagler had been researching the physiological origins of food allergy and potential treatments for over 30 years, but she hadn’t considered the possibility of translating that research into a business. But just 15 months after considering that possibility and beginning her entrepreneurial career, she is the founder of a promising, emerging venture.

A biotech startup hopes

The University of Chicago Innovation Fund announced plans to invest up to $500,000 into three companies—AVNovum, ClostraBio, and SwitchedSource—that are working in the health and energy fields, respectively.

2016 brought us the launch of several research-based startups, the invention of a new diamond-like coating, the deployment of data-collection nodes across Chicago and a next-generation platform for cancer research. Before getting too deep into the new year, here are 16 highlights in research and innovation at UChicago in 2016:

One name every food allergic person should know is Dr. Cathy Nagler. 

When Cathryn Nagler set out to develop drugs to treat childhood food allergies, she knew she was heading into unchartered territory. Although Nagler, the Bunning Food Allergy Professor, has been a research scientist for more than 30 years, she had no plans to go into business.

Meet The 30 Under 30: Science

There has been an unprecedented increase in food allergies in developed countries, rising by as much as 20 percent in the past decade. Allergy to cow’s milk is one of the most common, occurring in up to three percent of children worldwide.

Amid the trillions of microbes that live in the intestines, scientists have found a few species that seem to play a key role in keeping us healthy

Every single one of you has 100 trillion bacterial cells on you, and those 100 trillion cells are found all over your body

We are pleased to announce that a FARE-funded researcher, Dr. Cathryn Nagler of the University of Chicago, has received a multi-year, $1.4 million grant from the National Institutes of Health (NIH). Over several years, FARE has provided more than $1.5 million to Dr. Nagler and her team.